(Q39567517)

13 September 2017

title

Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells (English)

1 reference

13 September 2017

1 reference

1 reference

Xian-Jun Min

1

1 reference

13 September 2017

Hui Li

2

1 reference

13 September 2017

Sheng-Cai Hou

3

1 reference

13 September 2017

Wei He

4

1 reference

13 September 2017

Jie Liu

5

1 reference

13 September 2017

Bin Hu

6

1 reference

13 September 2017

Jun Wang

7

1 reference

13 September 2017

publication date

31 March 2011

1 reference

Experimental Biology and Medicine

13 September 2017

published in

1 reference

13 September 2017

volume

236

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

483-491

1 reference

Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Activation of volume-sensitive Cl(-) channel is involved in carboplatin-induced apoptosis in human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Volume-sensitive chloride channels (ICl,vol) mediate doxorubicin-induced apoptosis through apoptotic volume decrease in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Apoptosis, cell volume regulation and volume-regulatory chloride channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Cellular mechanisms for the repression of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

IK channels are involved in the regulatory volume decrease in human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Chloride channels involve in hydrogen peroxide-induced apoptosis of PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Suppression of ClC-3 channel expression reduces migration of nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Involvement of regulatory volume decrease in the migration of nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Sildenafil inhibits human pulmonary artery smooth muscle cell proliferation by decreasing capacitative Ca2+ entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Molecular characterization of the DYX1C1 gene and its application as a cancer biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Inhibition of SOC/Ca2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Molecular identification of a volume-regulated chloride channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Roles of volume-sensitive Cl- channel in cisplatin-induced apoptosis in human epidermoid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Chloride channel inhibition prevents ROS-dependent apoptosis induced by ischemia-reperfusion in mouse cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Anion channel blockers attenuate delayed neuronal cell death induced by transient forebrain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Protein kinase C-independent correlation between P-glycoprotein expression and volume sensitivity of Cl- channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010297

21 January 2018

Identifiers

DOI

10.1258/EBM.2011.010297

1 reference

13 September 2017

1 reference